Peptide receptor radionuclide therapy with 177lutethium or 90Yttrium-DOTA-TATE or -TOC in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): Results from a single institutional retrospective analysis Meeting Abstract


Authors: Rubino, M.; Di Stasio, G. D.; Spada, F.; Rocca, P. A.; Laffi, A.; Fazio, N.; Bodei, L.; Grana, C. M.
Abstract Title: Peptide receptor radionuclide therapy with 177lutethium or 90Yttrium-DOTA-TATE or -TOC in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): Results from a single institutional retrospective analysis
Meeting Title: 19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease
Keywords: paraganglioma; pheochromocytoma; 90y; 177lu; peptide receptor radionuclide therapy
Journal Title: Journal of Neuroendocrinology
Volume: 34
Issue: Suppl. 1
Meeting Dates: 2022 Mar 10-11
Meeting Location: Barcelona, Spain
ISSN: 0953-8194
Publisher: Wiley Blackwell  
Date Published: 2022-03-01
Start Page: e13108
Language: English
ACCESSION: WOS:000779149500145
PROVIDER: wos
PUBMED: 35253281
DOI: 10.1111/jne.13108
Notes: Meeting Abstract: H25 -- page 158 -- Meeting was also presented virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lisa   Bodei
    205 Bodei